Skip to content

Erythropoietin Gel Effect on Dental Implant Stability

Evaluation of Erythropoietin Gel Effect on Stability of Immediate Implant ( Clinical and Radiographical Study )

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06665451
Enrollment
24
Registered
2024-10-30
Start date
2025-03-15
Completion date
2026-07-01
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osseointegration

Brief summary

* Achieving and maintaining long-term osseointegration for dental implants is a key objective in the field of dentistry. The success of osseointegration is influenced by the surface treatment applied to dental implants. Numerous coating techniques have been developed to improve and speed up osseointegration. * The aim of the current study is to assess immediate dental implant stability coated with erythropoietin gel, both clinically and radiographically. * Materials and Methods: We conducted a randomized controlled clinical trial.The sample will include patients demanding immediate implant treatment in the anterior maxilla . Patients will be randomly allocated into the two groups of the study. The group A will be treated with erythropoietin gel coated dental implant immediately after extraction of non restorable teeth in the anterior maxilla . Group B will be treated with non coated dental implant immediately after extraction of non restorable teeth in the anterior maxilla . * The primary outcome variable will be implant stability and the secondary outcome will be crestal marginal bone level and bone density around implants. It will be measured at time of implant placement and reevaluated after 6-months .

Interventions

OTHERNon coated dental implants

Patients with fresh extraction sockets in the anterior maxilla will be treated by non coated immediate implant .

OTHERErythropoietin gel coated implants

Patients with fresh extraction sockets in the anterior maxilla will be treated by immediate implant coated by erythropoietin gel.

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* All patients Should have nonrestorable teeth in the anterior maxilla indicated for extraction and seeking implant placement. * Good general periodontal health and maintenance.

Exclusion criteria

* Heavy smokers who smoke more than ten cigarettes per day * Acute infected socket * Ant socket with wall defect. * Pregnency * Local or systemic conditions that will interfere with bone healing (uncontrolled diabetes mellitus or human immune deficiency virus infections, resonance therapy), bone disorders (hyperparathyroidism, osteoporosis, or Paget's disease. * Patients who had subjected to intravenous and/or oral bisphosphonate therapy.

Design outcomes

Primary

MeasureTime frameDescription
Change in implant stabilityBaseline and after 6 monthImplant stability will be assessed by using ( AnyCheck - Implant Stability Tester ) Utilizes physical tapping technique and dumping capacity analysis to measure implant stability with precision

Secondary

MeasureTime frameDescription
Change in marginal bone level and bone density around implantsBaseline and after 6 monthTo evaluate the amount of marginal bone loss and bone density around osseointegrated implants, all patient will be subjected to Cone beam computed tomography (CBCT) immediate postoperative and after 6 months.

Countries

Egypt

Contacts

CONTACTAhmed Mohsen Principle investigator
a7medmohsen453@gmail.com00201020994802
CONTACTMohamed Mahjob Head of oral and maxillofacial surgery department
00201001544056
STUDY_DIRECTORMohamed Alaa Lecturer of OMFS

faculty of Dental medicine Al-Azhar University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 19, 2026